Related references
Note: Only part of the references are listed.HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
Michael W. Fried et al.
HEPATOLOGY (2008)
New developments in HBV molecular diagnostics and quantitative serology
D. Scott Bowden et al.
HEPATOLOGY INTERNATIONAL (2008)
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B
Chih-Lin Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response
Man-Fung Yuen et al.
HEPATOLOGY (2007)
Role of viral factors in the natural course and therapy of chronic hepatitis B
Jia-Horng Kao
HEPATOLOGY INTERNATIONAL (2007)
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response
Henry Lik-Yuen Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
Stephen E. Livingston et al.
GASTROENTEROLOGY (2007)
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B
Chia-Ming Chu et al.
GASTROENTEROLOGY (2007)
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B
Jordan J. Feld et al.
HEPATOLOGY (2007)
Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay
Marie-Claire Chevrier et al.
TRANSFUSION (2007)
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
Chee-Kin Hui et al.
HEPATOLOGY (2007)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Appropriate use of interferon for treatment of chronic hepatitis B
Jia-Horng Kao
HEPATOLOGY RESEARCH (2007)
Spontaneous relapse of hepatitis in inactive HBsAg carriers
Chia-Ming Chu et al.
HEPATOLOGY INTERNATIONAL (2007)
Telbivudine: a new option for the treatment of chronic hepatitis B
Andres Ruiz-Sancho et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
C. -M. Chu et al.
JOURNAL OF VIRAL HEPATITIS (2007)
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study
Gang Chen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
Chee-Kin Hui et al.
GASTROENTEROLOGY (2006)
Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B
Yi-Wen Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases
BF Chen et al.
GASTROENTEROLOGY (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Therapy of hepatitis B - Viral suppression or eradication?
RP Perrillo
HEPATOLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Chronic hepatitis B: Current testing strategies
RG Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Therapeutic implications of hepatitis B virus genotypes
CJ Liu et al.
LIVER INTERNATIONAL (2005)
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline
CM Chu et al.
JOURNAL OF HEPATOLOGY (2005)
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
JJY Sung et al.
GASTROENTEROLOGY (2005)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
YF Liaw et al.
LIVER INTERNATIONAL (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
CM Chu et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
SH Yeh et al.
JOURNAL OF HEPATOLOGY (2004)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
JH Kao et al.
GASTROENTEROLOGY (2003)
Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan
JH Kao
INTERVIROLOGY (2003)
Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C
JH Kao et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Global control of hepatitis B virus infection
JH Kao et al.
LANCET INFECTIOUS DISEASES (2002)
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
MF Yuen et al.
HEPATOLOGY (2001)
Clinical relevance of hepatitis B viral mutations
CM Hunt et al.
HEPATOLOGY (2000)
Share Paper
